FDA Drug Safety Communication: New warnings against use of terbutaline to treat preterm labor
The FDA has released new warnings against use of the both the oral and injectable forms of the drug terbutaline for treatment of preterm labor. The drug should not be used in pregnant women for prevention or prolonged treatment of preterm labor in either the hospital or in outpatient settings because of the potential for […]